EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Due to the rapid emergence of the SARS-CoV-2 virus, molecular diagnostic technologies have expanded significantly. Although several diagnostic approaches were developed, real-time reverse ...
Transformative Biotech LLC, a Boulder-based company working to develop faster molecular tests for diseases such as COVID-19 and cancer, has appointed Mark Kelleher as executive vice president of ...
GREENWICH — How many people are getting their noses swabbed at COVID-19 testing sites anymore? Not many. Greenwich Hospital is conducting approximately 70 percent less molecular COVID-19 tests than it ...
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a novel virus that causes COVID-19 and has considerable variability in clinical outcomes among infected patients. The GENCOV study links ...
BOSTON & OXFORD, England & CAMBRIDGE, England & TORONTO--(BUSINESS WIRE)--Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement ...
The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...
A new study focuses on using computer algorithms to generate adaptations to molecules in compounds for existing and potential medications that can improve those molecules' ability to bind to the main ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results